Investigation Overview
April 6, 2015 (Shareholders Foundation) - An investigation on behalf of investors of Adamis Pharmaceuticals Corp (NASDAQ:ADMP) shares over potential securities laws violations by Adamis Pharmaceuticals and certain of its directors and officers in connection certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchasers o...
You must register (for free) or login to view the entire investigation.